Nadia Khan, MD

Dr. Khan is a medical oncologist with expertise in chronic lymphocytic leukemia and lymphomas. She is the Director of the CLL Division here at Swedish Cancer Institute and found her calling in caring for patients with compassion, hand-in-hand with offering cutting edge therapies based on the most recent advances in the field. Dr. Khan’s commitment to providing the latest, most effective and well-tolerated therapies for her patients translates directly to her role in developing clinical trials here at Swedish. A key tenet in her approach to care involves listening to what a patient’s particular needs are. Dr. Khan leads a multi-disciplinary care team here at Swedish, whose aim is to make this challenging experience as easy as possible for patients.